Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Incidence of serious bleeding events (sBE) in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab (BV) as part of a first-line regimen: Results from the BRiTE observational cohort study (OCS).
Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): Results from the BRiTE observational cohort study.
Principal Investigator
The making of a complex spike: ionic composition and plasticity.
Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract.
See All 11 Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Return to Top
Login
Username
Password